Name & Company Information Location Interests Events
user-icon

Geert 'T Jong, M.D., Ph.D.

University of Manitoba

Clinician Scientist

Winnipeg

Canada

Clinical Research Government Initiatives and Perspective—How to Enhance Development of Appropriate Formulation through Legislation and Funding
user-icon

Mike Abernathy

Amgen Inc.

Executive Director

To be Announced
Genzyme - Debora Aguiar

Deborah Aguiar

Sanofi

Director

Implementation of an Analytical Lifecycle Management Program
user-icon

Sreedhara Alavattam, Ph.D.

Genentech, Inc.

Principal Scientist

Fragile—Handle with Care: Drug Product Handling
user-icon

John Alexander, M.D.

U.S. Food and Drug Administration

Deputy Director

Global Pediatric Development: An FDA Pediatrician’s Perspective
user-icon

Shashi Amur, Ph.D.

U.S. Food and Drug Administration

Scientific Adviser, Office of Translational Sciences

Biomarkers, Clinical Trials, Drug Development, Genomics, Imaging, Microarrays, Pharmacogenomics Role of Biomarker in Supporting Personalized Medicine Efforts
me6-10

Thomas Anchordoquy, Ph.D.

University of Colorado

Professor

Aurora

United States

Focus Group>New Delivery Modalities, New Delivery Modalities Overcoming Critical Barriers to Lipid-Based Gene Delivery
user-icon

Daniel Anderson, Ph.D.

Massachusetts Institute of Technology

Associate Professor, Chemical Engineering and Institute for Medical Engineering and Science

Cambridge

United States

-
user-icon

Sean Arlauckas, Ph.D.

Massachusetts General Hospital

Research Fellow

In Vivo Imaging Reveals a Tumor-Associated Macrophage–Mediated Resistance Pathway in Anti–PD-1 Therapy
AAEAAQAAAAAAAAOFAAAAJDNiNzNjNTU5LWNiMGEtNDJmZC1iYTEwLTYxOTliZDRhMGU1OQ

Mayssa Attar, Ph.D.

Allergan, Inc.

Vice President

Bioanalytical Testing, Biomarkers And Imaging, Clinical Pharmacology; PK/PD And Bioanalytics, Clinical Research, Discovery, Drug Development, Pharmacokinetics And Drug Disposition, Preclinical Toxicology Testing And IND Application Preclinical Development of a Topical Dermatological Drug Product
Sherif Badawy 6763

Sherif Badawy, Ph.D.

Bristol-Myers Squibb Company

Research Fellow

Focus Group>Preformulation, Focus Group>Process Development, Focus Group>Process Modeling And Simulation, Focus Group>QbD And Product Performance, Formulation Design And Development>Preformulation, Formulation Design And Development>Process Development, Formulation Design And Development>QbD And Product Performance, Manufacturing Science And Engineering>Process Development, Manufacturing Science And Engineering>Process Modeling And Simulation Current Overview of Compaction Simulation Technology and Its Application in Product Development
Steve.headshot.Ireland

Steven Baertschi, Ph.D.

Baertschi Consulting, LLC

President

Carmel

United States

Formulation; Delivery; Packaging Development, Product Characterization, Regulatory Review Analytical Life Cycle Management: Case Studies
P18

Annette Bak, Ph.D., M.B.A.

AstraZeneca

Sr Director

Molndal

Sweden

Biotechnology>Pharmaceuticals In Global Health, Biotechnology>Preformulation, Biotechnology>Protein Aggregation And Biological Consequences, Biotechnology>Therapeutic Protein Immunogenicity, Discovery, Drug Discovery Development Interface>Nanotechnology, Drug Discovery Development Interface>Targeted Drug Delivery And Prodrug, Focus Group>Excipients, Focus Group>Lipid-Based Drug Delivery Systems, Focus Group>Nanotechnology, Focus Group>New Delivery Modalities, Focus Group>Novel Technology, Focus Group>Oral Absorption, Focus Group>Pharmaceuticals In Global Health, Focus Group>Precision Medicine, Focus Group>Preformulation, Focus Group>Protein Aggregation And Biological Consequences, Focus Group>Targeted Drug Delivery And Prodrug, Focus Group>Therapeutic Protein Immunogenicity, Formulation Design And Development>Lipid-Based Drug Delivery Systems, Formulation Design And Development>Nanotechnology, Formulation; Delivery; Packaging Development, Manufacturing, New Delivery Modalities, Novel Technology, Pharmacokinetics And Drug Disposition, Pharmacokinetics; Pharmacodynamics; And Drug Metabolism>Targeted Drug Delivery And Prodrug, Physical Pharmacy And Biopharmaceutics>Oral Absorption, Precision Medicine, Preclinical Research, Product Characterization, Regulatory Sciences>Excipients, Regulatory Sciences>Protein Aggregation And Biological Consequences Mid-Career Interviewing on a Global Playing Field
Daniel-1

Associate Professor Prof. Bar-Shalom, Ph.D.

University of Copenhagen

Associate Professor

Hoersholm

Denmark

Analysis Pharmaceutical Quality>In Vitro Release And Dissolution Testing, Biotechnology>Preformulation, Clinical Pharmacology Translational Science>Pharmaco-imaging, Drug Discovery Development Interface>Oral Absorption, Focus Group>Excipients, Focus Group>In Vitro Release And Dissolution Testing, Focus Group>Inhalation And Nasal Technology, Focus Group>Modified Release, Focus Group>Oral Absorption, Focus Group>Pharmaco-imaging, Focus Group>Preformulation, Formulation Design / Devel., Formulation Design/Development>In Vitro Release And Dissolution Testing, Formulation Design/Development>Inhalation And Nasal Technology, Formulation Design/Development>Modified Release, Formulation Design/Development>Preformulation, Manufacturing Science Engineering>Modified Release, PK/PD And Drug Metabolism>Oral Absorption, PK/PD And Drug Metabolism>Pharmaco-imaging, Physical Pharm Biopharm, Regulatory Sciences>Excipients Swallowability in Children—Where to Find Inspiration for Age-Appropriate Formulations
Headshot 2017

Stephanie Barrett, Ph.D.

Merck Research Laboratories

Principle Scientist, Biopharmaceutics and Specialty Dosage Forms

West Point

United States

Extended Duration Parenteral Products as Patient Adherence Strategies
jeremy_bartlett_small

Jeremy Bartlett, Ph.D.

Pfizer Inc.

Associate Research Fellow

Oral Multiparticulates as a Pediatric Platform—How to Make Good Medicines Not Taste Bad
user-icon

Jeremy Bartlett, Ph.D.

Pfizer Inc.

Associate Research Fellow

-
user-icon

Hal Baseman

ValSource LLC

Chief Operating Officer

The Process Validation Lifecycle—Science and Improvement—An Industry Perspective
IMG_7482

CAPT Edward Bashaw, Pharm.D.

U.S. Food and Drug Administration

Director

Silver Spring

United States

Bioanalytical Testing, Clinical Research, Discovery, Pharmacokinetics And Drug Disposition, Regulatory Review A Regulatory Perspective on Precision Medicine for Topical Products
051

Dr Hannah Batchelor, Ph.D.

University of Birmingham

Senior Lecturer in Pharmaceutics, Formulation and Drug Delivery

Birmingham

United Kingdom

De-Risking Pediatric Clinical Studies—A Proposed Process Based on a Typical Development Pathway